Anacin
- Product NDC
- 63736-200
- Requested package NDC
- 63736-200-95
- 11-digit product format
- 637360200
- Labeler code
- 63736
- Product ID
- 63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Asprin and Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Insight Pharmaceuticals LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2009-06-25
- Substance
- ASPIRIN; CAFFEINE
- Active strength
- 400; 32 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63736-200 | 63736-200-95 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anacin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 400 mg/1 |
| CAFFEINE | 32 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-200-04 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-04 | Anacin | 4 in 1 BLISTER PACK | TABLET | 4 | 9 | |
| 63736-200-30 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-30 | Anacin | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 63736-200-50 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-50 | Anacin | 50 in 1 BOTTLE | TABLET | 50 | 9 | |
| 63736-200-90 | Anacin | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 63736-200-90 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 130 in 1 BOTTLE | TABLET | 130 | 9 | |
| 63736-200-92 | Anacin | 125 in 1 BOX | TABLET | 125 | 9 | |
| 63736-200-92 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 | |
| 63736-200-93 | Anacin | 300 in 1 BOTTLE | TABLET | 300 | 9 | |
| 63736-200-93 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-95 | Anacin | 750 in 1 BOX | TABLET | 750 | 9 | |
| 63736-200-95 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Aspirin | ACTIVE INGREDIENT | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE INGREDIENT | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Aspirin | ACTIVE MOIETY | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE MOIETY | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | b16ed4ef-689c-4df2-ab6c-207aa8b9925d | 2026-11-02 | Warnings | M013 |
| acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | dc430980-5994-4e61-ad3d-181f5fdc769d | 2026-11-02 | Warnings | M013 |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | ARMY AND AIR FORCE EXCHANGE SERVICE | f1157dbc-d86c-4554-954c-60a74674ff6b | 2026-11-02 | Warnings | M013 |
| equate pain reliever | ACETAMINOPHEN | WALMART INC. | 59d01f72-4575-48e2-b914-b6a6456ca7d2 | 2026-11-02 | Warnings | M013 |
| equate aspirin chewable | ASPIRIN | Wal-Mart Stores Inc | 9147c0ce-fcdb-457c-b9f5-e4edd66e91d0 | 2026-11-01 | Warnings | M013 |
| Muscle and Joint Pain Reliever Cream Ultra Strength | MUSCLE AND JOINT CREAM | Savvy Care & Cosmetics Pvt. Ltd. | 5f215bd6-e7e9-59e3-e063-6394a90a169a | 2026-10-31 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 9cdfa6fb-4bc5-4a54-93fc-edd84bf80ef3 | 2026-10-30 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | LEADER/ Cardinal Health 110, Inc. | b3773f02-02a9-33c8-e053-2995a90a2235 | 2026-10-30 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | 6ec12573-03d6-40c1-9945-d345b401e062 | 2026-10-30 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Meijer | 181aee35-8fb2-35e4-e063-6394a90a6b3b | 2026-10-29 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN 500MG | Demoulas Super Markets, Inc. | 36dbcb69-40b9-495b-b5a1-60693f06145d | 2026-10-28 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | 06a0fc1f-4cac-4d0f-9349-90a0fb4cc0c8 | 2026-10-28 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | Bi-Mart | 35483db0-d6b8-4b37-8113-1dbe51e42ae5 | 2026-10-28 | Warnings | M013 |
| Pain Relief Rapid Release Gelcaps Extra Strength | ACETAMINOPHEN | Safeway | c830d1ac-c4c5-4eb1-98bb-22707cb6db91 | 2026-10-28 | Warnings | M013 |
| Adult Low Dose Aspirin | ASPIRIN | HYVEE INC | 45ae4509-fb50-66fd-e063-6294a90a2d7b | 2026-10-28 | Warnings | M013 |
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | 4cc4b39a-39d5-a2bb-e063-6394a90a2e95 | 2026-10-28 | Warnings | M013 |
| Gencare-Aspirin Low Dose Pain reliever (NSAID) | ASPIRIN | Pioneer Life Sciences, LLC | 24d4f46a-c7a5-4e94-804f-1e307d8e8cfc | 2026-10-28 | Warnings | M013 |
| Aspirin | ASPIRIN | Chain Drug Marketing Association, Inc. | 2d375ec9-a528-4048-a15b-652fa20e74a7 | 2026-10-28 | Warnings | M013 |
| Aspirin Enteric Coated | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | f1ce15a3-9824-4eb5-910a-39078165f385 | 2026-10-28 | Warnings | M013 |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | L.N.K. International, Inc. | ec902e52-0f48-4a61-b67d-17e1c1461619 | 2026-10-28 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 211292 | ANACIN 400 MG / 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin] | SBD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | SCD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | Anacin (ASA 400 MG / caffeine 32 MG) Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | ASA 400 MG / Caffeine 32 MG Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | ASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin] | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63736-200-95 | 63736020095 | 750 POUCH in 1 BOX (63736-200-95) > 1 TABLET in 1 POUCH | 750 pouch | 2009-06-25 | 2023-06-30 | No | No | Current |